Search

Issue
Title
Authors
Endocrine resistance in breast cancer treatment
Dzhelyalova M.A., Semiglazov V.F.
Alpelisib for the treatment of HR+HER2-metastatic breast cancer in patients with the PIK3CA mutation: results of the SOLAR-1 study
Semiglazova T.Y., Semiglazov V.V., Klimenko V.V., Brish N.A., Alekseeva Y.V., Klyuge V.A., Krutov A.A., Paltuev R.M., Kasparov B.S., Krivorotko P.V., Semiglazov V.F.
Ways to improve endocrine therapy in postmenopausal women with ER+/ HER2- breast cancer
Dzhelyalova M.A., Semiglazov V.F.
Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
Grechukhina K.S., Vorontsova K.A., Kuko T.M., Prosvirnov A.A., Ganshina I.P., Lubennikova E.V., Kolyadina I.V., Zhukova L.G.
1 - 4 of 4 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"